Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-021463)

Filing Details

Accession Number:: 0001209191-18-021463
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-23 17:40:55
Reporting Period:: 2018-03-19

Accepted Time:: 2018-03-23 17:40:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1666790	Michael Bonner	2525 West End Avenue, Suite 950 Nashville TN 37203	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-19	300	$6.72	15,997	No	4	P	Direct
Common Stock	Acquisiton	2018-03-23	2,500	$6.70	18,497	No	4	A	Direct
Common Stock	Disposition	2018-03-23	843	$6.70	17,654	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	A	Direct
No	4	F	Direct

Footnotes

Restricted stock award will vest 100% on March 20, 2022.
This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.